Galectin-3 in urine of cancer patients: stage and tissue specificity
- First Online:
- 199 Downloads
Galectin-3 has been implicated in advanced stage of cancer disease. In the current study we examined the possibility of urinary galectin-3 levels to stage cancer disease and to follow up therapy.
Urine was collected from all types of cancer patients at different stages including patients undergoing radio/chemotherapy. Galectin-3 level was determined by anti-galectin-3 based ELISA and agglutination assays. Immunoblotting and purification on lactosyl affinity column further confirmed the presence of galectin-3.
Cancer samples exhibited stage dependent expression of galectin-3 approx. ranging from 1.0 to 3.3, 4.4 to 5.4, 5.4 to 24.7, 13.1 to 31.9, 13.9 to 32.9 ng/mg C (creatinine) for stage I–V, respectively, at P ~ <0.05 level. Galectin-3 levels were decreased by approx. threefolds after 5th day of therapy.
Sample collection being simple and non-invasive, urinary galectin-3 may be used as a potential diagnostic tool for monitoring or follow up of the stage of cancer disease.
KeywordsGalectin-3 Hemagglutination Creatinine Metastasis Radio/chemotherapy Urine
- Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A (1997) Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer Res 80:776–787Google Scholar
- Herrmann J, Truck CW, Atchison RE, Huflej ME, Poulter L, Gitt MA et al (1993) Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous proline, glycine, tyrosine rich sequence with bacterial and tissue collagenase. J Biol Chem 208:26704–26711Google Scholar
- Lotz MM, Andrews CW, Korzelins CA, Lee EC, Steele GD, Jrclarke A et al (1993) Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 90:3466–3470. doi:10.1073/pnas.90.8.3466 PubMedCrossRefGoogle Scholar
- Nangia-Makker P, Akahani S, Bresalier R, Raz A (2000) The role of galectin-3 in tumor metastasis. In: Lectins and pathology. Taylor and Francis Incorporation, LondonGoogle Scholar
- Song YK, Billiar TR, Lee YJ (2002) Am J Pathol 160:1069–1075Google Scholar
- Van den Brule FA, Castronovo V (2000) Laminin binding lectins during invasion and metastasis. In: Lectins and pathology. Taylor and Francis Inc., LondonGoogle Scholar